The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Procalcitonin increase in early identification of critically ill patients at high risk of mortality*
Abstract
OBJECTIVE: To investigate day-by-day changes in procalcitonin and maximum obtained levels as predictors of mortality in critically ill patients. DESIGN: Prospective observational cohort study. SETTING: : Multidisciplinary intensive care unit at Rigshospitalet, Copenhagen University Hospital, a tertiary reference hospital in Denmark. PATIENTS: Four hundred seventy-two patients with diverse comorbidity and age admitted to this intensive care unit. INTERVENTIONS: Equal in all patient groups: antimicrobial treatment adjusted according to the procalcitonin level. MEASUREMENTS AND MAIN RESULTS: Daily procalcitonin measurements were carried out during the study period as well as measurements of white blood cell count and C-reactive protein and registration of comorbidity. The primary end point was all-cause mortality in a 90-day follow-up period. Secondary end points were mortality during the stay in the intensive care unit and in a 30-day follow-up period. A total of 3,642 procalcitonin measurements were evaluated in 472 critically ill patients. We found that a high maximum procalcitonin level and a procalcitonin increase for 1 day were independent predictors of 90-day all-cause mortality in the multivariate Cox regression analysis model. C-reactive protein and leukocyte increases did not show these qualities. The adjusted hazard ratio for procalcitonin increase for 1 day was 1.8 (95% confidence interval 1.3-2.7). The relative risk for mortality in the intensive care unit for patients with an increasing procalcitonin was as follows: after 1 day increase, 1.8 (95% confidence interval 1.4-2.4); after 2 days increase, 2.2 (95% confidence interval 1.6-3.0); and after 3 days increase: 2.8 (95% confidence interval 2.0-3.8). CONCLUSIONS: A high maximum procalcitonin level and a procalcitonin increase for 1 day are early independent predictors of all-cause mortality in a 90-day follow-up period after intensive care unit admission. Mortality risk increases for every day that procalcitonin increases. Levels or increases of C-reactive protein and white blood cell count do not seem to predict mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
High serum procalcitonin concentrations in patients with sepsis and infection
Assicot, M., Bohuon, C., Gendrel, D., Raymond, J., Carsin, H., & Guilbaud, J. (1993) · The Lancet · doi:10.1016/0140-6736(93)90277-n · Cited by 2,197
Simon, L., Gauvin, F., Amre, D. K., Saint-Louis, P., & Lacroix, J. (2004) · Clinical Infectious Diseases · doi:10.1086/421997 · Cited by 1,787
Christ-Crain, M., Jaccard-Stolz, D., Bingisser, R., Gencay, M. M., Huber, P. R., Tamm, M., & Müller, B. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15591-8 · Cited by 1,096
Procalcitonin increase after endotoxin injection in normal subjects
Dandona, P. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.6.1605 · Cited by 965
Garnacho-Montero, J., Garcia-Garmendia, J. L., Barrero-Almodovar, A., Jimenez-Jimenez, F. J., Perez-Paredes, C., & Ortiz-Leyba, C. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000098031.24329.10 · Cited by 718
Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro
Nijsten, M. W. N., Olinga, P., The, H. T., de Vries, E. G. E., Koops, H. S., Groothuis, G. M. M., Limburg, P. C., ten Duis, H. J., Moshage, H., Hoekstra, H. J., et al. (2000) · Critical Care Medicine · doi:10.1097/00003246-200002000-00028 · Cited by 295
Alberti, C., Brun-Buisson, C., Goodman, S. V., Guidici, D., Granton, J., Moreno, R., Smithies, M., Thomas, O., Artigas, A., & Le Gall, J. R. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200208-785oc · Cited by 262
Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit
Balci, C., Sungurtekin, H., Gürses, E., Sungurtekin, U., & Kaptanoğlu, B. (2002) · Critical Care · doi:10.1186/cc1843 · Cited by 225
Hatherill, M., Tibby, S. M., Turner, C., Ratnavel, N., & Murdoch, I. A. (2000) · Critical Care Medicine · doi:10.1097/00003246-200007000-00068 · Cited by 178
Procalcitonin and its Component Peptides in Systemic Inflammation: Immunochemical Characterization
Snider, R. H., Nylen, E. S., & Becker, K. L. (1997) · Journal of Investigative Medicine · doi:10.1177/108155899704500911 · Cited by 166
Cited by
Sepsis: a roadmap for future research
Cohen, J., Vincent, J.-L., Adhikari, N. K. J., Machado, F. R., Angus, D. C., Calandra, T., Jaton, K., Giulieri, S., Delaloye, J., Opal, S., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)70112-x · Cited by 992
Use of Procalcitonin to Shorten Antibiotic Treatment Duration in Septic Patients
Nobre, V., Harbarth, S., Graf, J.-D., Rohner, P., & Pugin, J. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200708-1238oc · Cited by 605
Becker, K. L., Snider, R., & Nylen, E. S. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e318165babb · Cited by 598
Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis.
Nursing, M. R. I. C. U., Fowler, A. A., Syed, A. A., Knowlson, S., Sculthorpe, R., Farthing, D., DeWilde, C., Farthing, C. A., Larus, T. L., Martin, E., et al. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-32 · Cited by 573
Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future
Schuetz, P., Albrich, W., & Mueller, B. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-107 · Cited by 528
Metadata
- Authors
- Jensen, J. U., Heslet, L., Jensen, T. H., Espersen, K., Steffensen, P., & Tvede, M.
- Venue
- Critical Care Medicine
- Published
- 2006-10
- Volume
- 34
- Issue
- 10
- Pages
- 2596-2602
- ISSN
- 0090-3493 (ISSN-L)
- OpenAlex
- W1975477886
- Cited by
- 380
- References
- 18
- FWCI
- 16.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Procalcitonin increase in early identification of critically ill patients at high risk of mortality*. https://app.cochat.ai/papers/10.1097/01.ccm.0000239116.01855.61
- The paper
- Jensen, J. U., Heslet, L., Jensen, T. H., Espersen, K., Steffensen, P., & Tvede, M. (2006). Procalcitonin increase in early identification of critically ill patients at high risk of mortality*. Critical Care Medicine. https://doi.org/10.1097/01.ccm.0000239116.01855.61
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.